Dr Lal Pathlabs Ltd

Dr Lal Pathlabs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Lal Pathlabs Ltd

₹ 2,245 -3.56%
18 Apr - close price
lalpathlabs.com BSE: 539524 NSE : LALPATHLAB
About

Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates. [1]

Key Points

About[1]
It is the largest diagnostics chain with a PAN India presence and a consistent track record of quality and growth. The company has 70+ yrs of experience in the field of diagnostics. The company has serviced 111 Mn+ patients
in the last 5 years.

Website BSE NSE
  • Market Cap ₹ 18,737 Cr.
  • Current Price ₹ 2,245
  • High / Low ₹ 2,767 / 1,881
  • Stock P/E 51.2
  • Book Value ₹ 217
  • Dividend Yield 0.80 %
  • ROCE 22.1 %
  • ROE 18.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 35.2%

Cons

  • Stock is trading at 10.4 times its book value
  • The company has delivered a poor sales growth of 11.6% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
427 404 565 470 422 416 440 467 429 431 480 532 476
296 291 392 337 323 311 331 337 325 315 344 369 346
Operating Profit 131 113 173 133 100 105 110 130 105 116 136 163 130
OPM % 31% 28% 31% 28% 24% 25% 25% 28% 24% 27% 28% 31% 27%
15 13 14 15 11 13 19 8 9 12 15 14 15
Interest 4 4 4 4 9 11 8 10 8 8 7 7 6
Depreciation 18 18 17 18 19 22 19 21 21 21 18 19 19
Profit before tax 124 105 165 126 83 85 102 106 84 98 125 151 120
Tax % 25% 25% 25% 25% 26% 23% 22% 26% 26% 27% 25% 25% 26%
93 79 123 94 62 65 80 79 63 71 94 113 88
EPS in Rs 11.12 9.44 14.79 11.27 7.40 7.83 9.56 9.43 7.51 8.56 11.22 13.54 10.58
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
319 421 541 637 765 882 1,024 1,165 1,274 1,491 1,879 1,769 1,919
240 334 406 486 562 651 768 882 946 1,083 1,366 1,308 1,374
Operating Profit 79 87 135 151 204 230 256 283 328 408 512 461 545
OPM % 25% 21% 25% 24% 27% 26% 25% 24% 26% 27% 27% 26% 28%
2 3 8 17 20 28 31 46 58 51 53 47 56
Interest 3 0 0 0 0 1 1 1 15 15 29 34 29
Depreciation 18 18 31 32 32 26 31 36 68 70 76 82 78
Profit before tax 61 71 111 135 192 231 256 292 303 374 461 391 494
Tax % 32% 31% 34% 32% 34% 34% 34% 33% 26% 25% 25% 25%
41 49 74 92 126 152 168 195 223 280 345 292 366
EPS in Rs 1,222.72 1,456.93 137.77 16.80 15.21 18.36 20.19 23.45 26.78 33.61 41.42 35.07 43.90
Dividend Payout % 21% 11% 8% 9% 16% 16% 22% 26% 45% 60% 29% 17%
Compounded Sales Growth
10 Years: 15%
5 Years: 12%
3 Years: 12%
TTM: 9%
Compounded Profit Growth
10 Years: 20%
5 Years: 12%
3 Years: 9%
TTM: 28%
Stock Price CAGR
10 Years: %
5 Years: 16%
3 Years: -8%
1 Year: 18%
Return on Equity
10 Years: 25%
5 Years: 23%
3 Years: 23%
Last Year: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 3 3 54 55 83 83 83 83 83 83 83 83 84
Reserves 107 147 135 238 397 503 693 847 933 1,134 1,389 1,606 1,726
Preference Capital 2 2 27 27 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 38 385 281 278
60 102 142 157 112 90 119 136 302 318 354 350 304
Total Liabilities 170 252 331 449 592 676 896 1,067 1,318 1,573 2,211 2,320 2,392
84 91 114 119 130 121 173 173 297 300 371 361 347
CWIP 6 1 0 1 4 17 9 3 11 9 14 5 10
Investments 23 80 20 49 74 134 174 214 253 171 1,062 1,213 1,165
58 80 197 280 384 404 540 677 757 1,093 764 740 870
Total Assets 170 252 331 449 592 676 896 1,067 1,318 1,573 2,211 2,320 2,392

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
63 79 96 94 142 167 189 208 272 373 426 428
-22 -56 -86 -86 -148 -134 -166 -93 -19 -195 -449 -288
-38 -15 -10 1 1 -32 13 -54 -187 -136 141 -270
Net Cash Flow 3 9 0 9 -5 1 36 61 65 42 118 -131

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 16 17 16 17 17 17 14 17 14 16 13 13
Inventory Days 37 31 33 44 40 70 38 32 22
Days Payable 89 88 97 104 110 143 132 101 131
Cash Conversion Cycle 16 17 16 -35 -41 -47 -45 -54 -59 -79 -55 -96
Working Capital Days -23 -38 -28 -10 28 15 18 1 -16 -16 -15 -21
ROCE % 57% 54% 61% 51% 48% 44% 38% 34% 33% 34% 31% 22%

Shareholding Pattern

Numbers in percentages

20 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
55.23% 55.23% 55.23% 55.23% 55.05% 55.04% 55.04% 55.03% 55.01% 54.61% 54.60% 54.60%
26.42% 26.82% 25.45% 23.44% 22.37% 23.26% 25.80% 24.89% 23.27% 24.35% 25.36% 26.15%
6.54% 5.73% 6.57% 6.83% 6.52% 6.27% 6.20% 6.56% 8.34% 8.85% 9.27% 9.40%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.29% 0.29% 0.29% 0.29%
10.96% 11.42% 12.01% 13.80% 15.46% 14.84% 12.38% 13.01% 12.65% 11.48% 10.12% 9.24%
0.85% 0.80% 0.74% 0.70% 0.60% 0.58% 0.56% 0.51% 0.44% 0.41% 0.37% 0.32%
No. of Shareholders 94,1231,25,9531,35,0681,71,8461,84,5081,71,6021,79,6361,80,1631,74,4441,60,6791,49,9011,46,741

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls